PMCID
string
Sentences
string
ner
list
PMC9429973
The most deleterious effects were observed in whole hemolysate conditions in which, an important quantity of RBC large-size particles (> 2 μm) mostly positive for C3 was detected.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "The", "most", "deleterious", "effects", "were", "observed", "in", "whole", "hemolysate", "conditions", "in", "which", ",", "an", "important", "quantity", "of", "RBC", "large-size", "particles", "(", ">", "2", "μm", ")", "mostly", "positive", "for", "C3", "was", "detected", "." ] } ]
PMC11394730
The mechanism of action was associated with an increase in pro-apoptotic Bax expression and a decrease in anti-apoptotic Bcl-2 expression.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "The", "mechanism", "of", "action", "was", "associated", "with", "an", "increase", "in", "pro-apoptotic", "Bax", "expression", "and", "a", "decrease", "in", "anti-apoptotic", "Bcl-2", "expression", "." ] } ]
PMC11468365
The mean synergy scores of the proposed model are 232.37, 9.59, 0.57, 0.76, and 0.73 for the previous metrics, respectively.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "The", "mean", "synergy", "scores", "of", "the", "proposed", "model", "are", "232.37", ",", "9.59", ",", "0.57", ",", "0.76", ",", "and", "0.73", "for", "the", "previous", "metrics", ",", "respectively", "." ] } ]
PMC11519567
Notably, the phase separation is disrupted when tyrosine is mutated to alanine, and at the same time, the regulatory ability of SS18 in the process of pluripotency to somatic cell conversion is also changed .
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Notably", ",", "the", "phase", "separation", "is", "disrupted", "when", "tyrosine", "is", "mutated", "to", "alanine", ",", "and", "at", "the", "same", "time", ",", "the", "regulatory", "ability", "of", "SS18", "in", "the", "process", "of", "pluripotency", "to", "somatic", "cell", "conversion", "is", "also", "changed", "." ] } ]
PMC9429973
Antibiotic type was determined by review of medical records.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Antibiotic", "type", "was", "determined", "by", "review", "of", "medical", "records", "." ] } ]
PMC9429973
Inhibition of viral replication with passive immunization proved to be efficient and safe.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Inhibition", "of", "viral", "replication", "with", "passive", "immunization", "proved", "to", "be", "efficient", "and", "safe", "." ] } ]
PMC11033180
While the mutation S951C had no impact on the promoting effect of Sema5A-Fc on synapse density, the mutation S956G inhibited the ability of Sema5A-Fc to enhance synapse density (Figures 5D–5F; p = 0.005, ANOVA with Dunn’s post-test).
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "While", "the", "mutation", "S951C", "had", "no", "impact", "on", "the", "promoting", "effect", "of", "Sema5A-Fc", "on", "synapse", "density", ",", "the", "mutation", "S956", "G", "inhibited", "the", "ability", "of", "Sema5A-Fc", "to", "enhance", "synapse", "density", "(", "Figures", "5D–5F", ";", "p", "=", "0.005", ",", "ANOVA", "with", "Dunn", "’s", "post-test", ")", "." ] } ]
PMC11740907
Over the course of 24 h, HeLa cells were subjected to varying concentrations of pure P5W30 and P5W30-BW-SLNs.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "B-CellLine", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Over", "the", "course", "of", "24", "h", ",", "HeLa", "cells", "were", "subjected", "to", "varying", "concentrations", "of", "pure", "P5W30", "and", "P5W30-BW-SLNs", "." ] } ]
PMC11525028
G and H) Proliferation (G) and migration (H) of RNAi-mediated functional screening targeting 28 genes in GFP 143B cells.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-CellLine", "O", "O" ], "tokens": [ "G", "and", "H", ")", "Proliferation", "(", "G", ")", "and", "migration", "(", "H", ")", "of", "RNAi-mediated", "functional", "screening", "targeting", "28", "genes", "in", "GFP", "143B", "cells", "." ] } ]
PMC11525028
Cell proliferation assays showed that both paliperidone (143B IC50 = 10.81 μM, HOS IC50 = 7.73 μM) and AG-401 (143B IC50 = 26.80 μM, HOS IC50 = 22.03 μM) suppressed tumor cell growth (Figure S5D).
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "B-CellLine", "O", "O", "O", "O", "O", "B-CellLine", "O", "O", "O", "O", "O", "O", "O", "O", "B-CellLine", "O", "O", "O", "O", "O", "B-CellLine", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Cell", "proliferation", "assays", "showed", "that", "both", "paliperidone", "(", "143B", "IC50", "=", "10.81", "μM", ",", "HOS", "IC50", "=", "7.73", "μM", ")", "and", "AG-401", "(", "143B", "IC50", "=", "26.80", "μM", ",", "HOS", "IC50", "=", "22.03", "μM", ")", "suppressed", "tumor", "cell", "growth", "(", "Figure", "S5D", ")", "." ] } ]
PMC9429973
These findings support the development of anti-ROR1 cell therapies for the potential treatment of ROR1-positive hematological malignancies.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "These", "findings", "support", "the", "development", "of", "anti-ROR1", "cell", "therapies", "for", "the", "potential", "treatment", "of", "ROR1-positive", "hematological", "malignancies", "." ] } ]
PMC11643361
The cytotoxicity of the two most active complexes of this set (23 and 24) were also tested against rapidly proliferating non-tumoral human embryonic kidney HEK293 cells and displayed IC50 values about four times higher than cisplatin, but also displayed a selectivity index about three times higher than that of cisplatin, suggesting a preferential cytotoxicity of 23 and 24 toward neoplastic cells .
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "The", "cytotoxicity", "of", "the", "two", "most", "active", "complexes", "of", "this", "set", "(", "23", "and", "24", ")", "were", "also", "tested", "against", "rapidly", "proliferating", "non-tumoral", "human", "embryonic", "kidney", "HEK293", "cells", "and", "displayed", "IC50", "values", "about", "four", "times", "higher", "than", "cisplatin", ",", "but", "also", "displayed", "a", "selectivity", "index", "about", "three", "times", "higher", "than", "that", "of", "cisplatin", ",", "suggesting", "a", "preferential", "cytotoxicity", "of", "23", "and", "24", "toward", "neoplastic", "cells", "." ] } ]
PMC11615218
Interestingly, recent evidence has also suggested that CAR structures affect the exhaustion status of CAR-T cells .
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Interestingly", ",", "recent", "evidence", "has", "also", "suggested", "that", "CAR", "structures", "affect", "the", "exhaustion", "status", "of", "CAR-T", "cells", "." ] } ]
PMC9429973
Image: Summary/Conclusion: Evaluation of plasma circulating cfDNA might be an effective approach for molecular diagnosis in MM.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Image", ":", "Summary/Conclusion", ":", "Evaluation", "of", "plasma", "circulating", "cfDNA", "might", "be", "an", "effective", "approach", "for", "molecular", "diagnosis", "in", "MM", "." ] } ]
PMC10938336
In this case, only target proteins with a probability value greater than or equal to 0.7 were considered as potential targets.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "In", "this", "case", ",", "only", "target", "proteins", "with", "a", "probability", "value", "greater", "than", "or", "equal", "to", "0.7", "were", "considered", "as", "potential", "targets", "." ] } ]
PMC10565698
We constructed a Venn diagram and identified three common intersections: TCF12, CREB5, and ELOVL6 (Fig. 6A).
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "We", "constructed", "a", "Venn", "diagram", "and", "identified", "three", "common", "intersections", ":", "TCF12", ",", "CREB5", ",", "and", "ELOVL6", "(", "Fig.", "6A", ")", "." ] } ]
PMC11200978
Mechanistic investigations revealed a predominant role of necroptosis in cell death following combination treatment.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Mechanistic", "investigations", "revealed", "a", "predominant", "role", "of", "necroptosis", "in", "cell", "death", "following", "combination", "treatment", "." ] } ]
PMC11794588
The Solanaceae family is significant for both medicinal and economic plants.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "The", "Solanaceae", "family", "is", "significant", "for", "both", "medicinal", "and", "economic", "plants", "." ] } ]
PMC6442998
SFPQ, a transcription factor of PDE3A, was also less abundant in GIST48 cells.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-CellLine", "O", "O" ], "tokens": [ "SFPQ", ",", "a", "transcription", "factor", "of", "PDE3A", ",", "was", "also", "less", "abundant", "in", "GIST48", "cells", "." ] } ]
PMC9985266
As expected, the mRNA and protein expression of the fibrosis-related proteins α-SMA, FN, and COL I significantly rebounded, and the fluorescence intensity was enhanced after 3-MA treatment compared with the IL-27 group (Fig. 2D–H; Additional file 1: Fig. S5C).
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "As", "expected", ",", "the", "mRNA", "and", "protein", "expression", "of", "the", "fibrosis-related", "proteins", "α-SMA", ",", "FN", ",", "and", "COL", "I", "significantly", "rebounded", ",", "and", "the", "fluorescence", "intensity", "was", "enhanced", "after", "3-MA", "treatment", "compared", "with", "the", "IL-27", "group", "(", "Fig.", "2D", "–", "H", ";", "Additional", "file", "1", ":", "Fig.", "S5C", ")", "." ] } ]
PMC11628904
Larvae were treated with medium supplemented with NaCl to a final concentration of 10 mOsm (Control), 135 mOsm or 270 mOsm (Isotonic).
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Larvae", "were", "treated", "with", "medium", "supplemented", "with", "NaCl", "to", "a", "final", "concentration", "of", "10", "mOsm", "(", "Control", ")", ",", "135", "mOsm", "or", "270", "mOsm", "(", "Isotonic", ")", "." ] } ]
PMC11381192
Decision curve analysis (DCA) of the nomogram and other features in predicting 2‐, 3‐ and 5‐year OS outcomes.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Decision", "curve", "analysis", "(", "DCA", ")", "of", "the", "nomogram", "and", "other", "features", "in", "predicting", "2‐", ",", "3‐", "and", "5‐year", "OS", "outcomes", "." ] } ]
PMC7136814
Subsequent testing of a 3-drug combination of Vincristine with the TPA/GSK126 differentiation therapy approach demonstrated a partial override of cells chemoresistance.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Subsequent", "testing", "of", "a", "3-drug", "combination", "of", "Vincristine", "with", "the", "TPA/GSK126", "differentiation", "therapy", "approach", "demonstrated", "a", "partial", "override", "of", "cells", "chemoresistance", "." ] } ]
PMC10887351
The β-ARs signaling pathways, including the β3-AR subtype, imply AC stimulation, which induces cAMP production .
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "The", "β-ARs", "signaling", "pathways", ",", "including", "the", "β3-AR", "subtype", ",", "imply", "AC", "stimulation", ",", "which", "induces", "cAMP", "production", "." ] } ]
PMC10674574
The permeability values of the tested compounds should be reported only if the TEER after the transport experiment is at least 75% of the initial value (before the experiment) .
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "The", "permeability", "values", "of", "the", "tested", "compounds", "should", "be", "reported", "only", "if", "the", "TEER", "after", "the", "transport", "experiment", "is", "at", "least", "75", "%", "of", "the", "initial", "value", "(", "before", "the", "experiment", ")", "." ] } ]
PMC11394730
Moreover, Anthocyanins have a potent antioxidant potential because they can scavenge free radicals, which work to lower DNA damage and prevent the growth of tumors .
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Moreover", ",", "Anthocyanins", "have", "a", "potent", "antioxidant", "potential", "because", "they", "can", "scavenge", "free", "radicals", ",", "which", "work", "to", "lower", "DNA", "damage", "and", "prevent", "the", "growth", "of", "tumors", "." ] } ]
PMC10761218
Previous studies on W. somnifera leaf and root methanolic extracts have indicated that they are a source of novel phytochemicals that can inhibit cancer [25–28].
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Previous", "studies", "on", "W.", "somnifera", "leaf", "and", "root", "methanolic", "extracts", "have", "indicated", "that", "they", "are", "a", "source", "of", "novel", "phytochemicals", "that", "can", "inhibit", "cancer", "[", "25–28", "]", "." ] } ]
PMC11615828
The gene “mCh‐CIBN‐Rab3‐SL2‐EMTB‐RFPnano‐Cry2” was synthesized and subsequently subcloned into a vector under the phSP16/2 promoter.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "The", "gene", "“", "mCh‐CIBN‐Rab3‐SL2‐EMTB‐RFPnano‐Cry2", "”", "was", "synthesized", "and", "subsequently", "subcloned", "into", "a", "vector", "under", "the", "phSP16/2", "promoter", "." ] } ]
PMC11252553
The evaluation of Taurine’s ability to scavenge DPPH free radicals, compared to cysteine, revealed that Taurine is not as potent as cysteine in terms of radical scavenging.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "The", "evaluation", "of", "Taurine", "’s", "ability", "to", "scavenge", "DPPH", "free", "radicals", ",", "compared", "to", "cysteine", ",", "revealed", "that", "Taurine", "is", "not", "as", "potent", "as", "cysteine", "in", "terms", "of", "radical", "scavenging", "." ] } ]
PMC10440586
The expression profile of samples from bevacizumab-treated patients was obtained under the accession of GSE79671 , and the expression data of mouse tumor samples bearing glioma xenografts treated with different drugs was obtained under the accession of GSE39413 .
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "The", "expression", "profile", "of", "samples", "from", "bevacizumab-treated", "patients", "was", "obtained", "under", "the", "accession", "of", "GSE79671", ",", "and", "the", "expression", "data", "of", "mouse", "tumor", "samples", "bearing", "glioma", "xenografts", "treated", "with", "different", "drugs", "was", "obtained", "under", "the", "accession", "of", "GSE39413", "." ] } ]
PMC11721295
Considerable heterogeneity in lung cancer has prevented efficacy of new targeted immune therapies, with only approximately 11% of all lung cancer patients responding to ICI therapy.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Considerable", "heterogeneity", "in", "lung", "cancer", "has", "prevented", "efficacy", "of", "new", "targeted", "immune", "therapies", ",", "with", "only", "approximately", "11", "%", "of", "all", "lung", "cancer", "patients", "responding", "to", "ICI", "therapy", "." ] } ]
PMC11066331
The TUSC3 protein constitutes a subunit of the oligosaccharyltransferase subunit, contributing to the final steps of N-glycosylation of proteins in endoplasmic reticulum .
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "The", "TUSC3", "protein", "constitutes", "a", "subunit", "of", "the", "oligosaccharyltransferase", "subunit", ",", "contributing", "to", "the", "final", "steps", "of", "N-glycosylation", "of", "proteins", "in", "endoplasmic", "reticulum", "." ] } ]
PMC11194678
>300 cells were assessed blind and quantified for each batch.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ ">", "300", "cells", "were", "assessed", "blind", "and", "quantified", "for", "each", "batch", "." ] } ]
PMC11758416
n = 6 (B) Comparison of cell death of L cells pre-incubated with anti-CD3 OKT3 clone vs. SK7 clone following incubation with CD8 T cells.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-CellLine", "O", "O", "O", "O", "O", "O", "O", "B-CellLine", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "n", "=", "6", "(", "B", ")", "Comparison", "of", "cell", "death", "of", "L", "cells", "pre-incubated", "with", "anti-CD3", "OKT3", "clone", "vs.", "SK7", "clone", "following", "incubation", "with", "CD8", "T", "cells", "." ] } ]
PMC8414691
Three independent IP experiments were performed.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Three", "independent", "IP", "experiments", "were", "performed", "." ] } ]
PMC11049294
They encode the 429 amino acid long AGAL enzyme.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "They", "encode", "the", "429", "amino", "acid", "long", "AGAL", "enzyme", "." ] } ]
PMC11543885
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD045862.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "The", "mass", "spectrometry", "proteomics", "data", "have", "been", "deposited", "to", "the", "ProteomeXchange", "Consortium", "via", "the", "PRIDE", "partner", "repository", "with", "the", "dataset", "identifier", "PXD045862", "." ] } ]
PMC8524093
Using a BHK-21 cell model, Santos and colleagues analyzed the potential antiviral properties of the snake venom phospholipase A2CB (PLA2CB) on CHIKV replication cycle and demonstrated that this molecule inhibits CHIKV entry process (Santos et al., 2021).
[ { "tags": [ "O", "O", "B-CellLine", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Using", "a", "BHK-21", "cell", "model", ",", "Santos", "and", "colleagues", "analyzed", "the", "potential", "antiviral", "properties", "of", "the", "snake", "venom", "phospholipase", "A2CB", "(", "PLA2CB", ")", "on", "CHIKV", "replication", "cycle", "and", "demonstrated", "that", "this", "molecule", "inhibits", "CHIKV", "entry", "process", "(", "Santos", "et", "al.", ",", "2021", ")", "." ] } ]
PMC11658074
Human ADSCs were isolated from fat mass as described previously .
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Human", "ADSCs", "were", "isolated", "from", "fat", "mass", "as", "described", "previously", "." ] } ]
PMC11769516
Mycotoxins produced by Penicillium spp.,
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Mycotoxins", "produced", "by", "Penicillium", "spp", ".", "," ] } ]
PMC8913139
Functionally, miR-448 inhibited the invasion and proliferation of gastric cancer cells by controlling ADAM10 .
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Functionally", ",", "miR-448", "inhibited", "the", "invasion", "and", "proliferation", "of", "gastric", "cancer", "cells", "by", "controlling", "ADAM10", "." ] } ]
PMC11252553
Then, all models were centrifuged (12,000 rpm, 2 min), and their related absorbance was measured at 517 nm by a spectrophotometer.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Then", ",", "all", "models", "were", "centrifuged", "(", "12,000", "rpm", ",", "2", "min", ")", ",", "and", "their", "related", "absorbance", "was", "measured", "at", "517", "nm", "by", "a", "spectrophotometer", "." ] } ]
PMC9429973
Part 1 is a safety run-in comprising 2 safety cohorts with ~6 pts receiving sabatolimab 400 mg + AZA + VEN and ~12 pts receiving sabatolimab 800 mg + AZA + VEN.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Part", "1", "is", "a", "safety", "run-in", "comprising", "2", "safety", "cohorts", "with", "~6", "pts", "receiving", "sabatolimab", "400", "mg", "+", "AZA", "+", "VEN", "and", "~12", "pts", "receiving", "sabatolimab", "800", "mg", "+", "AZA", "+", "VEN", "." ] } ]
PMC11765879
Previously, ZSC anti-cancer effects have been examined in vitro against different cancer types such as breast, liver, cervical, colon, and lung .
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Previously", ",", "ZSC", "anti-cancer", "effects", "have", "been", "examined", "in", "vitro", "against", "different", "cancer", "types", "such", "as", "breast", ",", "liver", ",", "cervical", ",", "colon", ",", "and", "lung", "." ] } ]
PMC9429973
Methods: Between June 2014 and January 2019, 194 eligible patients with pre-sternum diagnosis of acquired hypocellular BMFS in our center were retrospectively reviewed.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Methods", ":", "Between", "June", "2014", "and", "January", "2019", ",", "194", "eligible", "patients", "with", "pre-sternum", "diagnosis", "of", "acquired", "hypocellular", "BMFS", "in", "our", "center", "were", "retrospectively", "reviewed", "." ] } ]
PMC9429973
IDIBAPS.
[ { "tags": [ "O", "O" ], "tokens": [ "IDIBAPS", "." ] } ]
PMC10761571
Reza Ghasemian: Resources.
[ { "tags": [ "O", "O", "O", "O", "O" ], "tokens": [ "Reza", "Ghasemian", ":", "Resources", "." ] } ]
PMC8633974
While curative measures for HIV-1 are under development, gene editing stands alone in having the ability to remove the virus independently from host antiviral adaptive immunity.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "While", "curative", "measures", "for", "HIV-1", "are", "under", "development", ",", "gene", "editing", "stands", "alone", "in", "having", "the", "ability", "to", "remove", "the", "virus", "independently", "from", "host", "antiviral", "adaptive", "immunity", "." ] } ]
PMC9268183
In the Catalan Pyrenees, this taxon is traditionally used for the treatment of “mal gra”, a Catalan term that translates into “bad pimple”, frequently used to designate some sort of skin cancer.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "In", "the", "Catalan", "Pyrenees", ",", "this", "taxon", "is", "traditionally", "used", "for", "the", "treatment", "of", "“", "mal", "gra", "”", ",", "a", "Catalan", "term", "that", "translates", "into", "“", "bad", "pimple", "”", ",", "frequently", "used", "to", "designate", "some", "sort", "of", "skin", "cancer", "." ] } ]
PMC10253973
The complex of Ru(II) with 2,2-bipyridine, 56, is a reference compound for the evaluation of Ru(II) compounds with photophysical and photochemical activity.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "The", "complex", "of", "Ru(II", ")", "with", "2,2-bipyridine", ",", "56", ",", "is", "a", "reference", "compound", "for", "the", "evaluation", "of", "Ru(II", ")", "compounds", "with", "photophysical", "and", "photochemical", "activity", "." ] } ]
PMC9429973
Primary CNS-lymphoma was excluded due to different treatment and prognosis.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Primary", "CNS-lymphoma", "was", "excluded", "due", "to", "different", "treatment", "and", "prognosis", "." ] } ]
PMC11759543
Combination drug treatment improves the expression of apoptosis-related proteins, including cleaved PARP, cleaved caspase 8, cleaved caspase 9, cleaved caspase-3, and γ-H2AX in both cell lines.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Combination", "drug", "treatment", "improves", "the", "expression", "of", "apoptosis-related", "proteins", ",", "including", "cleaved", "PARP", ",", "cleaved", "caspase", "8", ",", "cleaved", "caspase", "9", ",", "cleaved", "caspase-3", ",", "and", "γ-H2AX", "in", "both", "cell", "lines", "." ] } ]
PMC8992508
The Hoechst 33342 accumulation assay was used to investigate their inhibitory activity on BCRP overexpressing MDCK II cell line; the activity on P-gp overexpressing A2780 adr cell line and MRP1 overexpressing H69AR cell line was studied using the calcein AM accumulation assay.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-CellLine", "I-CellLine", "O", "O", "O", "O", "O", "O", "O", "O", "B-CellLine", "I-CellLine", "O", "O", "O", "O", "O", "B-CellLine", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "The", "Hoechst", "33342", "accumulation", "assay", "was", "used", "to", "investigate", "their", "inhibitory", "activity", "on", "BCRP", "overexpressing", "MDCK", "II", "cell", "line", ";", "the", "activity", "on", "P-gp", "overexpressing", "A2780", "adr", "cell", "line", "and", "MRP1", "overexpressing", "H69AR", "cell", "line", "was", "studied", "using", "the", "calcein", "AM", "accumulation", "assay", "." ] } ]
PMC9503669
These studies show that Src-family kinase activation is a conserved feature of HIV-1 Nef alleles, and that activation of this kinase pathway is important for efficient HIV-1 replication.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "These", "studies", "show", "that", "Src-family", "kinase", "activation", "is", "a", "conserved", "feature", "of", "HIV-1", "Nef", "alleles", ",", "and", "that", "activation", "of", "this", "kinase", "pathway", "is", "important", "for", "efficient", "HIV-1", "replication", "." ] } ]
PMC9424261
A, B GSH and Fe content in liver cancer cells with or without HERPUD1 after adding erastin, RSL3, CA.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "A", ",", "B", "GSH", "and", "Fe", "content", "in", "liver", "cancer", "cells", "with", "or", "without", "HERPUD1", "after", "adding", "erastin", ",", "RSL3", ",", "CA", "." ] } ]
PMC9429973
SmCEBPA bZIP mutant pts and those with other CEBPA mutations and favorable ELN2017 genotype also show an improved outcome.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "SmCEBPA", "bZIP", "mutant", "pts", "and", "those", "with", "other", "CEBPA", "mutations", "and", "favorable", "ELN2017", "genotype", "also", "show", "an", "improved", "outcome", "." ] } ]
PMC3203927
Differentiation status and culture vessel difference didn't affect the overall gene expression pattern (Figure 1, top).
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Differentiation", "status", "and", "culture", "vessel", "difference", "did", "n't", "affect", "the", "overall", "gene", "expression", "pattern", "(", "Figure", "1", ",", "top", ")", "." ] } ]
PMC10507284
Usually, glyceraldehyde 3‐phosphate dehydrogenase (GAPDH) is selected as an internal reference, and the relative expression level of TROAP is calculated by the 2^ method.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Usually", ",", "glyceraldehyde", "3‐phosphate", "dehydrogenase", "(", "GAPDH", ")", "is", "selected", "as", "an", "internal", "reference", ",", "and", "the", "relative", "expression", "level", "of", "TROAP", "is", "calculated", "by", "the", "2^", "method", "." ] } ]
PMC11367146
Fig. 6 SASA plot of (A) apo-BCL2, BCL2-daucosterol and BCL2-gigantol (B) apo-ESR1, ESR1-daucosterol and ESR1-gigantol (C) apo-MMP9, MMP9-daucosterol and MMP9-gigantol complex.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Fig.", "6", "SASA", "plot", "of", "(", "A", ")", "apo-BCL2", ",", "BCL2-daucosterol", "and", "BCL2-gigantol", "(", "B", ")", "apo-ESR1", ",", "ESR1-daucosterol", "and", "ESR1-gigantol", "(", "C", ")", "apo-MMP9", ",", "MMP9-daucosterol", "and", "MMP9-gigantol", "complex", "." ] } ]
PMC6600253
GRNVAC1/2, GV1001, GX301, and VX-001 are typical anticancer vaccines that are currently in clinical trials.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "GRNVAC1/2", ",", "GV1001", ",", "GX301", ",", "and", "VX-001", "are", "typical", "anticancer", "vaccines", "that", "are", "currently", "in", "clinical", "trials", "." ] } ]
PMC11190062
In conclusion, our results support that infections may not only be detrimental to patient health but also provide a survival benefit for cancer cells, making them less responsive to proteasome inhibition and to drugs targeting BCMA.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "In", "conclusion", ",", "our", "results", "support", "that", "infections", "may", "not", "only", "be", "detrimental", "to", "patient", "health", "but", "also", "provide", "a", "survival", "benefit", "for", "cancer", "cells", ",", "making", "them", "less", "responsive", "to", "proteasome", "inhibition", "and", "to", "drugs", "targeting", "BCMA", "." ] } ]
PMC11676674
Gallocatechin isolated from Paliurus spina-christi Mill.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Gallocatechin", "isolated", "from", "Paliurus", "spina-christi", "Mill", "." ] } ]
PMC11656657
Our preclinical xenograft mouse model of OS seems to exclude the direct involvement of CXCL8 in favoring the expansion of murine MDSC.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Our", "preclinical", "xenograft", "mouse", "model", "of", "OS", "seems", "to", "exclude", "the", "direct", "involvement", "of", "CXCL8", "in", "favoring", "the", "expansion", "of", "murine", "MDSC", "." ] } ]
PMC10999934
KEGG analysis of DEGs.
[ { "tags": [ "O", "O", "O", "O", "O" ], "tokens": [ "KEGG", "analysis", "of", "DEGs", "." ] } ]
PMC9429973
At data cutoff, 55% of patients were still on FEDR.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "At", "data", "cutoff", ",", "55", "%", "of", "patients", "were", "still", "on", "FEDR", "." ] } ]
PMC10482220
First, endogenous G3BP is very efficiently recruited to SGs after stress.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "First", ",", "endogenous", "G3BP", "is", "very", "efficiently", "recruited", "to", "SGs", "after", "stress", "." ] } ]
PMC4485786
Note the high congruity within a cohort. (
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Note", "the", "high", "congruity", "within", "a", "cohort", ".", "(" ] } ]
PMC11760643
Plates were incubated overnight at 37°C and 95% air/5% CO2.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Plates", "were", "incubated", "overnight", "at", "37", "°", "C", "and", "95", "%", "air/5", "%", "CO2", "." ] } ]
PMC8956657
Because HKU5 ORF4b had been studied previously and shown to traffic to the nucleus, and an analysis of the two NLS domains between the two viruses revealed only minor differences (Fig. 7B and Supplementary Fig. 14), we examined how differences could potentially result in changes in the mode of IMPα binding.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Because", "HKU5", "ORF4b", "had", "been", "studied", "previously", "and", "shown", "to", "traffic", "to", "the", "nucleus", ",", "and", "an", "analysis", "of", "the", "two", "NLS", "domains", "between", "the", "two", "viruses", "revealed", "only", "minor", "differences", "(", "Fig.", "7B", "and", "Supplementary", "Fig.", "14", ")", ",", "we", "examined", "how", "differences", "could", "potentially", "result", "in", "changes", "in", "the", "mode", "of", "IMPα", "binding", "." ] } ]
PMC11634794
Similarly, esophageal squamous cell carcinoma (ESCC) demonstrates a positive correlation between LAMP1 expression levels and TNM staging; higher TNM stages correspond to increased expression levels of LAMP1 (20).
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Similarly", ",", "esophageal", "squamous", "cell", "carcinoma", "(", "ESCC", ")", "demonstrates", "a", "positive", "correlation", "between", "LAMP1", "expression", "levels", "and", "TNM", "staging", ";", "higher", "TNM", "stages", "correspond", "to", "increased", "expression", "levels", "of", "LAMP1", "(", "20", ")", "." ] } ]
PMC9429973
As a result, mitochondria in th3 HSCs are impaired, with low mass and activity, as assessed by decreased mitochondrial membrane potential.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "As", "a", "result", ",", "mitochondria", "in", "th3", "HSCs", "are", "impaired", ",", "with", "low", "mass", "and", "activity", ",", "as", "assessed", "by", "decreased", "mitochondrial", "membrane", "potential", "." ] } ]
PMC11786767
CDK1 inhibitor treatment alters nuclear lipid distribution.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "CDK1", "inhibitor", "treatment", "alters", "nuclear", "lipid", "distribution", "." ] } ]
PMC11507371
The expression of pro-inflammatory genes like IL-1B, IL-6, and CXCL8 was downregulated in A431 cells upon CAP treatment.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-CellLine", "O", "O", "O", "O", "O" ], "tokens": [ "The", "expression", "of", "pro-inflammatory", "genes", "like", "IL-1B", ",", "IL-6", ",", "and", "CXCL8", "was", "downregulated", "in", "A431", "cells", "upon", "CAP", "treatment", "." ] } ]
PMC11678448
The percentage of apoptosis in circulating lymphocytes at various time points indicated that the apoptosis rate in the control group ranged from 0.8% to 1.4%.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "The", "percentage", "of", "apoptosis", "in", "circulating", "lymphocytes", "at", "various", "time", "points", "indicated", "that", "the", "apoptosis", "rate", "in", "the", "control", "group", "ranged", "from", "0.8", "%", "to", "1.4", "%", "." ] } ]
PMC11381192
In the training cohort, Kaplan–Meier curves demonstrated that patients with high CSI had significantly inferior OS and event‐free survival (EFS) rates compared to those with low CSI (Figure 2D,E).
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "In", "the", "training", "cohort", ",", "Kaplan", "–", "Meier", "curves", "demonstrated", "that", "patients", "with", "high", "CSI", "had", "significantly", "inferior", "OS", "and", "event‐free", "survival", "(", "EFS", ")", "rates", "compared", "to", "those", "with", "low", "CSI", "(", "Figure", "2D", ",", "E", ")", "." ] } ]
PMC11476106
In contrast, after 3 weeks of culture, in both scaffolds (HGs without and with added VN; Figure 3C,D) approximately 80% of clusters contained fewer cells, each with small nuclei, reduced cytoplasm, and wide intercellular spaces.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "In", "contrast", ",", "after", "3", "weeks", "of", "culture", ",", "in", "both", "scaffolds", "(", "HGs", "without", "and", "with", "added", "VN", ";", "Figure", "3C", ",", "D", ")", "approximately", "80", "%", "of", "clusters", "contained", "fewer", "cells", ",", "each", "with", "small", "nuclei", ",", "reduced", "cytoplasm", ",", "and", "wide", "intercellular", "spaces", "." ] } ]
PMC10891340
At 7, 8, 9 and 10 hpi, the infected cells were collected to extract DNA.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "At", "7", ",", "8", ",", "9", "and", "10", "hpi", ",", "the", "infected", "cells", "were", "collected", "to", "extract", "DNA", "." ] } ]
PMC9429973
Aims: The primary objectives are to evaluate safety and tolerability and to determine the maximum tolerated dose (Phase 1a), and to evaluate the early clinical activity of NX-2127 in expansion cohorts (Phase 1b).
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Aims", ":", "The", "primary", "objectives", "are", "to", "evaluate", "safety", "and", "tolerability", "and", "to", "determine", "the", "maximum", "tolerated", "dose", "(", "Phase", "1a", ")", ",", "and", "to", "evaluate", "the", "early", "clinical", "activity", "of", "NX-2127", "in", "expansion", "cohorts", "(", "Phase", "1b", ")", "." ] } ]
PMC9429973
The ORR and CR are consistent with those seen in DYNAMO.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "The", "ORR", "and", "CR", "are", "consistent", "with", "those", "seen", "in", "DYNAMO", "." ] } ]
PMC11388384
This outcome suggests that a single biochemical parameter can regulate both SHH secretion and diffusion under the topology-limited diffusion model (Fig. 4B and SI Appendix, Fig. S10).
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "This", "outcome", "suggests", "that", "a", "single", "biochemical", "parameter", "can", "regulate", "both", "SHH", "secretion", "and", "diffusion", "under", "the", "topology-limited", "diffusion", "model", "(", "Fig.", "4B", "and", "SI", "Appendix", ",", "Fig.", "S10", ")", "." ] } ]
PMC11188874
Cells were harvested 48 hours after transfection, washed with PBS, lysates prepared under nondenaturing conditions and immunoprecipitated using the Pierce anti-DYKDDDDK affinity resin for 2 hours at 4°C followed with elution with the Pierce 3X DYKDDDDK peptide.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Cells", "were", "harvested", "48", "hours", "after", "transfection", ",", "washed", "with", "PBS", ",", "lysates", "prepared", "under", "nondenaturing", "conditions", "and", "immunoprecipitated", "using", "the", "Pierce", "anti-DYKDDDDK", "affinity", "resin", "for", "2", "hours", "at", "4", "°", "C", "followed", "with", "elution", "with", "the", "Pierce", "3X", "DYKDDDDK", "peptide", "." ] } ]
PMC4277423
Seven days after the transduction CCR5 expression on the surface of transduced TZM.bl cells was measured by antibody staining followed by FACS analysis (see below).
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Seven", "days", "after", "the", "transduction", "CCR5", "expression", "on", "the", "surface", "of", "transduced", "TZM.bl", "cells", "was", "measured", "by", "antibody", "staining", "followed", "by", "FACS", "analysis", "(", "see", "below", ")", "." ] } ]
PMC11766174
Thus, samples with larger numbers of cells need to be separately loaded onto multiple slides.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Thus", ",", "samples", "with", "larger", "numbers", "of", "cells", "need", "to", "be", "separately", "loaded", "onto", "multiple", "slides", "." ] } ]
PMC9503541
The bioactive GE fractions were subjected to LC-MS/MS analysis using the Waters Xevo G2-S QTof instrument.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "The", "bioactive", "GE", "fractions", "were", "subjected", "to", "LC-MS/MS", "analysis", "using", "the", "Waters", "Xevo", "G2-S", "QTof", "instrument", "." ] } ]
PMC11194678
Recombinant proteins were expressed in Escherichia coli Rosetta host cells in LB medium, and E. coli were cultured with OD600 around 0.6–0.8 and induced with IPTG at 16°C overnight.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Recombinant", "proteins", "were", "expressed", "in", "Escherichia", "coli", "Rosetta", "host", "cells", "in", "LB", "medium", ",", "and", "E.", "coli", "were", "cultured", "with", "OD600", "around", "0.6–0.8", "and", "induced", "with", "IPTG", "at", "16", "°", "C", "overnight", "." ] } ]
PMC11783017
The experimental procedure was performed as shown in Fig. 6A.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "The", "experimental", "procedure", "was", "performed", "as", "shown", "in", "Fig.", "6A", "." ] } ]
PMC11021472
Thus, our results suggest that the effect of circZDHHC11 on BL growth does not involve MYB or other components of the network.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Thus", ",", "our", "results", "suggest", "that", "the", "effect", "of", "circZDHHC11", "on", "BL", "growth", "does", "not", "involve", "MYB", "or", "other", "components", "of", "the", "network", "." ] } ]
PMC11513571
Then, the A549 cells were stimulated with rSP (5 μg/mL), poly I:C (500 ng/mL).
[ { "tags": [ "O", "O", "O", "B-CellLine", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Then", ",", "the", "A549", "cells", "were", "stimulated", "with", "rSP", "(", "5", "μg/mL", ")", ",", "poly", "I", ":", "C", "(", "500", "ng/mL", ")", "." ] } ]
PMC11541409
: p. 3918-3928.This reference is of outstanding importance because it reports that ripretinib has the similar effcicay with sunitinib as a second line therapy drug for GIST patients after imatinib failure.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ ":", "p.", "3918", "-", "3928.This", "reference", "is", "of", "outstanding", "importance", "because", "it", "reports", "that", "ripretinib", "has", "the", "similar", "effcicay", "with", "sunitinib", "as", "a", "second", "line", "therapy", "drug", "for", "GIST", "patients", "after", "imatinib", "failure", "." ] } ]
PMC9429973
Summary/Conclusion: Stratification according to cytogenetic risk groups is very important for the prognostic assessment of MDS patients.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Summary/Conclusion", ":", "Stratification", "according", "to", "cytogenetic", "risk", "groups", "is", "very", "important", "for", "the", "prognostic", "assessment", "of", "MDS", "patients", "." ] } ]
PMC11746948
LC-MS/MS analyses were performed using an UHPLC system (1290, Agilent Technologies), equipped with a Kinetex C18 column (2.1 × 100 mm, 1.7 μm, Phenomen).
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "LC-MS/MS", "analyses", "were", "performed", "using", "an", "UHPLC", "system", "(", "1290", ",", "Agilent", "Technologies", ")", ",", "equipped", "with", "a", "Kinetex", "C18", "column", "(", "2.1", "×", "100", "mm", ",", "1.7", "μm", ",", "Phenomen", ")", "." ] } ]
PMC11320834
EPC and cholesterol were dissolved in chloroform, and stock solutions were mixed to obtain a molar ratio of 55:45.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "EPC", "and", "cholesterol", "were", "dissolved", "in", "chloroform", ",", "and", "stock", "solutions", "were", "mixed", "to", "obtain", "a", "molar", "ratio", "of", "55:45", "." ] } ]
PMC11564322
Unfortunately, in leukemia patients, ELANE is highly expressed and predicts poor survival .
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "Unfortunately", ",", "in", "leukemia", "patients", ",", "ELANE", "is", "highly", "expressed", "and", "predicts", "poor", "survival", "." ] } ]
PMC11438317
As before, immunoprecipitation after PV treatment for 5 min was used to examine these interactions in transiently transfected HEK293 cells.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-CellLine", "O", "O" ], "tokens": [ "As", "before", ",", "immunoprecipitation", "after", "PV", "treatment", "for", "5", "min", "was", "used", "to", "examine", "these", "interactions", "in", "transiently", "transfected", "HEK293", "cells", "." ] } ]
PMC11322866
In control MM cells, Lamin B1 was uniformly expressed in the inner nuclear envelope, which appeared as a clear and thin membrane.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "In", "control", "MM", "cells", ",", "Lamin", "B1", "was", "uniformly", "expressed", "in", "the", "inner", "nuclear", "envelope", ",", "which", "appeared", "as", "a", "clear", "and", "thin", "membrane", "." ] } ]
PMC6889484
For detection of α-tubulin, mouse anti-α-tubulin antibody (catalog #T9026, Sigma) was used at a 1:10,000 dilution.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "For", "detection", "of", "α-tubulin", ",", "mouse", "anti-α-tubulin", "antibody", "(", "catalog", "#", "T9026", ",", "Sigma", ")", "was", "used", "at", "a", "1:10,000", "dilution", "." ] } ]
PMC9454178
In contrast, overexpressed OSR1 increased c-KIT expression (Fig. 8J).
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "In", "contrast", ",", "overexpressed", "OSR1", "increased", "c-KIT", "expression", "(", "Fig.", "8J", ")", "." ] } ]
PMC7685376
WB analysis was also consistent with the results of flow cytometry.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "WB", "analysis", "was", "also", "consistent", "with", "the", "results", "of", "flow", "cytometry", "." ] } ]
PMC11473843
The complete list of primary and secondary antibodies used is included in the Reagents Table.
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "The", "complete", "list", "of", "primary", "and", "secondary", "antibodies", "used", "is", "included", "in", "the", "Reagents", "Table", "." ] } ]
PMC11555465
After 24 h, the morphology of bladder cancer 5637 cells was observed (Fig. 1A).
[ { "tags": [ "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-CellLine", "O", "O", "O", "O", "O", "O", "O", "O" ], "tokens": [ "After", "24", "h", ",", "the", "morphology", "of", "bladder", "cancer", "5637", "cells", "was", "observed", "(", "Fig.", "1A", ")", "." ] } ]